Pfizer Inc. (PFE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 28.18 |
| Open | 28.24 |
| Bid | 28.01 x 4000 |
| Ask | 28.02 x 3000 |
| Day's range | 27.92 - 28.28 |
| 52-week range | 25.20 - 40.37 |
| Volume | |
| Avg. volume | 42,707,775 |
| Market cap | 158.721B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | 1.68 (5.96%) |
| Ex-dividend date | 09 May 2024 |
| 1y target est | 31.37 |
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
GuruFocus.comDecoding Pfizer Inc (PFE): A Strategic SWOT Insight
Insightful Analysis of Pfizer Inc's Financial Health and Strategic Position
© 2024 Yahoo. All rights reserved.